![These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral use Initial These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral use Initial](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=label2.jpg&id=315587)
These highlights do not include all the information needed to use AMLODIPINE BESYLATE TABLETS safely and effectively. See full prescribing information for AMLODIPINE BESYLATE TABLETS. AMLODIPINE BESYLATE tablets, for oral use Initial
![Therapeutic drug monitoring of amlodipine and the Z-FHL/HHL ratio: Adherence tools in patients referred for apparent treatment-resistant hypertension Therapeutic drug monitoring of amlodipine and the Z-FHL/HHL ratio: Adherence tools in patients referred for apparent treatment-resistant hypertension](http://www.scielo.org.za/img/revistas/samj/v107n10/20t1.jpg)
Therapeutic drug monitoring of amlodipine and the Z-FHL/HHL ratio: Adherence tools in patients referred for apparent treatment-resistant hypertension
![Amlodipine Toxicity in Children Less Than 6 Years of Age: A Dose-Response Analysis Using National Poison Data System Data - ScienceDirect Amlodipine Toxicity in Children Less Than 6 Years of Age: A Dose-Response Analysis Using National Poison Data System Data - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0736467909000985-gr1.jpg)
Amlodipine Toxicity in Children Less Than 6 Years of Age: A Dose-Response Analysis Using National Poison Data System Data - ScienceDirect
![Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes | Open Heart Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes | Open Heart](https://openheart.bmj.com/content/openhrt/3/2/e000473/F2.large.jpg?width=800&height=600&carousel=1)
Amlodipine in hypertension: a first-line agent with efficacy for improving blood pressure and patient outcomes | Open Heart
![Comparison of the antiproteinuric effects of the calcium channel blockers benidipine and amlodipine administered in combination with angiotensin receptor blockers to hypertensive patients with stage 3–5 chronic kidney disease | Hypertension Research Comparison of the antiproteinuric effects of the calcium channel blockers benidipine and amlodipine administered in combination with angiotensin receptor blockers to hypertensive patients with stage 3–5 chronic kidney disease | Hypertension Research](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fhr.2009.11/MediaObjects/41440_2009_Article_BFhr200911_Fig1_HTML.gif)